PRLB vs XMTR vs VELO vs SSYS

For growth investors, Velo3D, Inc.

(VELO) is the stronger pick with 1120% revenue growth year-over-year, versus -3. 7% for Stratasys Ltd. (SSYS). Proto Labs, Inc. (PRLB) offers the better valuation at 77. 3x trailing P/E (37. 5x forward), making it the more compelling value choice. Analysts rate Xometry, Inc. (XMTR) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Proto Labs, Inc.

is actually cheaper at 37. 5x.

Over the past 5 years, Velo3D, Inc.

(VELO) delivered a total return of +25. 4%, compared to -59. 1% for Stratasys Ltd. (SSYS). Over 10 years, the gap is even starker: VELO returned +21. 7% versus SSYS's -60. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Stratasys Ltd.

(SSYS) is the lower-risk stock at 1. 79β versus Velo3D, Inc. 's 3. 88β — meaning VELO is approximately 117% more volatile than SSYS relative to the S&P 500. On balance sheet safety, Proto Labs, Inc. (PRLB) carries a lower debt/equity ratio of 1% versus 126% for Xometry, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Velo3D, Inc.

(VELO) is pulling ahead at 1120% versus -3. 7% for Stratasys Ltd. (SSYS). On earnings-per-share growth, the picture is similar: Velo3D, Inc. grew EPS 95. 0% year-over-year, compared to -18. 4% for Xometry, Inc.. Over a 3-year CAGR, VELO leads at 735. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Proto Labs, Inc.

(PRLB) is the more profitable company, earning 4. 0% net margin versus -155. 2% for Velo3D, Inc. — meaning it keeps 4. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRLB leads at 4. 9% versus -119. 5% for VELO. At the gross margin level — before operating expenses — SSYS leads at 47. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Proto Labs, Inc.

(PRLB) trades at 37. 5x forward P/E versus 117. 0x for Xometry, Inc. — 79. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VELO: 66. 2% to $20. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Proto Labs, Inc.

(PRLB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Velo3D, Inc. (VELO) carries a higher beta of 3. 88 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRLB: +13. 7%, VELO: +21. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PRLB (Industrials) and XMTR (Industrials) and VELO (Technology) and SSYS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PRLB is a small-cap quality compounder stock; XMTR is a small-cap high-growth stock; VELO is a small-cap high-growth stock; SSYS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.